Live Breaking News & Updates on Avalo Therapeutics Company Profile

Stay updated with breaking news from Avalo therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Up 23.8% in December

Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Free Report) was the recipient of a large growth in short interest in December. As of December 15th, there was short interest totalling 12,640,000 shares, a growth of 23.8% from the November 30th total of 10,210,000 shares. Based on an average trading volume of 51,393,300 shares, the short-interest ratio […] ....

Vr Adviser , Avalo Therapeutics Company Profile , Acadian Asset Management , Susquehanna International Group , Avalo Therapeutics Inc , Goldman Sachs Group Inc , Avalo Therapeutics , Get Free Report , Therapeutics Stock Down , International Group , Sachs Group , Avalo Therapeutics Daily , Nasdaq Avtx ,

Avalo Therapeutics (AVTX) Scheduled to Post Earnings on Wednesday

Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) will be announcing its earnings results on Wednesday, August 2nd. Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) last released its earnings results on Thursday, May 4th. The company reported ($0.85) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.97) by $0.12. The firm had […] ....

Armistice Capital , Royal Bank , Avalo Therapeutics Inc , Armistice Capital Llc , Alyeska Investment Group , Millennium Management , Goldman Sachs Group Inc , Caissa Capital Management Ltd , Avalo Therapeutics Company Profile , Renaissance Technologies , Avalo Therapeutics , Get Free Report , Caissa Capital Management , Sachs Group , Avalo Therapeutics Daily , Nasdaq Avtx ,

Avalo Therapeutics (AVTX) Set to Announce Earnings on Wednesday

Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) is scheduled to be releasing its earnings data on Wednesday, August 2nd. Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) last posted its earnings results on Thursday, May 4th. The company reported ($0.85) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.97) by $0.12. The business […] ....

Armistice Capital Llc , Renaissance Technologies , Susquehanna International Group , Royal Bank , Avalo Therapeutics Company Profile , Caissa Capital Management Ltd , Millennium Management , Avalo Therapeutics Inc , Goldman Sachs Group Inc , Securities Exchange Commission , Avalo Therapeutics , Get Free Report , Therapeutics Stock Down , Armistice Capital , Exchange Commission , Caissa Capital Management , International Group , Sachs Group , Avalo Therapeutics Daily , Nasdaq Avtx ,

Royal Bank of Canada Lowers Avalo Therapeutics (NASDAQ:AVTX) to Sector Perform

Royal Bank of Canada cut shares of Avalo Therapeutics (NASDAQ:AVTX – Free Report) from an outperform rating to a sector perform rating in a research note issued to investors on Tuesday morning, The Fly reports. Avalo Therapeutics Trading Down 13.2 % Shares of NASDAQ AVTX opened at $0.37 on Tuesday. The company has a market […] ....

Armistice Capital , Avalo Therapeutics Company Profile , Millennium Management , Alyeska Investment Group , Royal Bank , Great Point Partners , Armistice Capital Llc , Avalo Therapeutics Inc , Renaissance Technologies , Caissa Capital Management Ltd , Avalo Therapeutics , Free Report , Therapeutics Trading Down , Caissa Capital Management , Point Partners , Avalo Therapeutics Daily ,

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Major Shareholder Caissa Capital Management Ltd. Buys 3,000 Shares

Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) major shareholder Caissa Capital Management Ltd. acquired 3,000 shares of the firm’s stock in a transaction that occurred on Friday, June 16th. The stock was purchased at an average cost of $3.90 per share, for a total transaction of $11,700.00. Following the completion of the purchase, the insider […] ....

Armistice Capital , Great Point Partners , Avalo Therapeutics Company Profile , Alyeska Investment Group , Renaissance Technologies , Avalo Therapeutics Inc , Caissa Capital Management Ltd , Millennium Management , Avalo Therapeutics , Get Rating , Caissa Capital Management , Capital Management , Point Partners , Avalo Therapeutics Daily , Nasdaq Avtx , Insider Trading , Nsider Trades ,